India Biotech Startup Gets $4.2M for Shelf-Ready Cancer Care

A Gurugram company is developing cancer treatments that can be made in advance and stored, potentially making cutting-edge cell therapy available to more patients at lower costs.

East Ocyon Bio just raised $4.

2 million to move toward human trials of its made-in-India approach.